Can Chen
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 13
- Immune Cell Function and Interaction 5
- Immune cells in cancer 4
- T-cell and B-cell Immunology 4
- Atherosclerosis and Cardiovascular Diseases 3
- interferon and immune responses 2
- Immunotherapy and Immune Responses 2
- Co-authors
- Hen‐Wai Tsao (2 shared papers)Jiann‐Jong Chen (2 shared papers)Kejian Wang (1 shared paper)Haining Gan (1 shared paper)Hanzhen Xiong (1 shared paper)Nanqi Huang (1 shared paper)Weixiang Liang (1 shared paper)Tianfa Dong (1 shared paper)
- Journals
- Life Sciences (3 papers)Journal of Cardiovascular Pharmacology (2 papers)Disease Markers (2 papers)Electronics Letters (2 papers)Indoor Air (1 paper)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Can Chen
40 papers receiving 931 citations
Peers
Comparison fields: 5 of 111
- Immunology 266
- Oncology 259
- Cancer Research 123
- Molecular Biology 309
- Biological Psychiatry 9
Countries citing papers authored by Can Chen
This map shows the geographic impact of Can Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Chen more than expected).
Fields of papers citing papers by Can Chen
This network shows the impact of papers produced by Can Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Chen. The network helps show where Can Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Can Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 253 | |
| 2 | 1992 | 107 | |
| 3 | 2018 | 82 | |
| 4 | 2014 | 81 | |
| 5 | 2020 | 43 | |
| 6 | 2010 | 35 | |
| 7 | 2012 | 34 | |
| 8 | 2014 | 26 | |
| 9 | Circulating low IL-23: IL-35 cytokine ratio promotes progression associated with poor prognosisin breast cancer. | 2016 | 25 |
| 10 | 1988 | 24 | |
| 11 | 2022 | 22 | |
| 12 | 2019 | 20 | |
| 13 | 2023 | 19 | |
| 14 | 2021 | 19 | |
| 15 | 2022 | 17 | |
| 16 | 1992 | 15 | |
| 17 | 2018 | 12 | |
| 18 | 2022 | 12 | |
| 19 | 2023 | 11 | |
| 20 | 2005 | 11 |
About Can Chen
Can Chen is a scholar working on Immunology, Molecular Biology, Oncology, Electrical and Electronic Engineering and Plant Science, having authored 41 papers that have together received 966 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (5 papers), Immune cells in cancer (4 papers), T-cell and B-cell Immunology (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), interferon and immune responses (2 papers), Immunotherapy and Immune Responses (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Immunology (266 citations), Oncology (259 citations), Cancer Research (123 citations), Molecular Biology (309 citations) and Biological Psychiatry (9 citations). Can Chen has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Hen‐Wai Tsao, Jiann‐Jong Chen, Kejian Wang, Haining Gan, Hanzhen Xiong, Nanqi Huang, Weixiang Liang, Tianfa Dong, Dongzhi Cen and Guang‐Rong Yan. Their work appears in journals such as Life Sciences, Journal of Cardiovascular Pharmacology, Disease Markers, Electronics Letters and Indoor Air.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.